Mesa Laboratories, Inc. – NASDAQ:MLAB

Mesa Laboratories stock price today

$70.21
-62.85
-47.23%
Financial Health
0
1
2
3
4
5
6
7
8
9

Mesa Laboratories stock price monthly change

+26.11%
month

Mesa Laboratories stock price quarterly change

+26.11%
quarter

Mesa Laboratories stock price yearly change

+28.18%
year

Mesa Laboratories key metrics

Market Cap
716.56M
Enterprise value
921.22M
P/E
-2.93
EV/Sales
4.03
EV/EBITDA
-4.01
Price/Sales
3.16
Price/Book
4.46
PEG ratio
-0.30
EPS
-47.82
Revenue
228.07M
EBITDA
15.46M
Income
-257.81M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-107.56%
Oper. margin
5.37%
Gross margin
58.57%
EBIT margin
5.37%
EBITDA margin
6.78%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Mesa Laboratories stock price history

Mesa Laboratories stock forecast

Mesa Laboratories financial statements

Mesa Laboratories, Inc. (NASDAQ:MLAB): Profit margin
Dec 2021 54.69M -2.06M -3.77%
Mar 2022 58.87M -1.78M -3.03%
Mar 2023 55.59M 611K 1.1%
Mar 2024 58.90M -254.58M -432.2%
Mesa Laboratories, Inc. (NASDAQ:MLAB): Analyst Estimates
2026 247.66M 4.85M 1.96%
2027 270.4M 18.5M 6.84%
  • Analysts Price target

  • Financials & Ratios estimates

0.48%
Yield TTM
Mesa Laboratories, Inc. (NASDAQ:MLAB): Payout ratio
Payout ratio -1.41%
Mesa Laboratories, Inc. (NASDAQ:MLAB): Dividend Yield
2020 0.29%
2021 0.26%
2022 0.25%
2023 0.37%
2024 0.57%
Mesa Laboratories, Inc. (NASDAQ:MLAB): Debt to assets
Sep 2022 656231000 281.99M 42.97%
Dec 2022 662984000 275.77M 41.6%
Mar 2023 661832000 268.35M 40.55%
Mar 2024 446796000 301.40M 67.46%
Mesa Laboratories, Inc. (NASDAQ:MLAB): Cash Flow
Dec 2021 15.89M -302.85M 61.2M
Mar 2022 9.30M -782K -10.04M
Mar 2023 12.51M -1.02M -4.39M
Mar 2024 12.88M 426K -12.93M

Mesa Laboratories alternative data

Mesa Laboratories, Inc. (NASDAQ:MLAB): Employee count
Aug 2023 698
Sep 2023 698
Oct 2023 698
Nov 2023 698
Dec 2023 698
Jan 2024 698
Feb 2024 698
Mar 2024 698
Apr 2024 698
May 2024 698
Jun 2024 698
Jul 2024 698

Mesa Laboratories other data

62.02% -32.73%
of MLAB is owned by hedge funds
3.32M -1.75M
shares is hold by hedge funds

Mesa Laboratories, Inc. (NASDAQ:MLAB): Insider trades (number of shares)
Period Buy Sel
Dec 2023 0 1500
Sep 2024 0 1499
Oct 2024 0 5069
Transaction Date Insider Security Shares Price per share Total value Source
Sale
OWENS GARY M officer: Presiden.. Common Stock 2,551 $111.98 $285,651
Sale
OWENS GARY M officer: Presiden.. Common Stock 2,518 $113.62 $286,085
Sale
ARCHBOLD BRIAN DAVID officer: SVP Oper.. Common Stock 1,499 $125 $187,375
Option
SAKYS JOHN officer: CFO Common Stock 1,037 N/A N/A
Option
SAKYS JOHN officer: CFO Restricted Stock Units - 6 1,037 N/A N/A
Option
OWENS GARY M officer: Presiden.. Common Stock 3,301 N/A N/A
Option
OWENS GARY M officer: Presiden.. Restricted Stock Units - 8 3,301 N/A N/A
Option
ARCHBOLD BRIAN DAVID officer: SVP Oper.. Common Stock 845 N/A N/A
Option
ARCHBOLD BRIAN DAVID officer: SVP Oper.. Restricted Stock Units - 7 845 N/A N/A
Option
SULLIVAN JOHN JAMES director
Common Stock 1,074 N/A N/A
Patent
Application
Filling date: 1 Oct 2021 Issue date: 20 Jan 2022
Application
Filling date: 13 Apr 2021 Issue date: 6 Jan 2022
Grant
Filling date: 19 Nov 2019 Issue date: 12 Oct 2021
Application
Filling date: 19 Nov 2019 Issue date: 12 Mar 2020
Grant
Filling date: 16 Dec 2016 Issue date: 24 Dec 2019
Thursday, 7 November 2024
zacks.com
globenewswire.com
Wednesday, 2 October 2024
globenewswire.com
Monday, 26 August 2024
zacks.com
zacks.com
zacks.com
Monday, 5 August 2024
globenewswire.com
Monday, 8 July 2024
globenewswire.com
Wednesday, 5 June 2024
globenewswire.com
Friday, 31 May 2024
globenewswire.com
Wednesday, 22 May 2024
globenewswire.com
Monday, 8 April 2024
globenewswire.com
Zacks Investment Research
Monday, 1 April 2024
GlobeNewsWire
Thursday, 14 December 2023
GlobeNewsWire
Friday, 22 September 2023
Zacks Investment Research
Wednesday, 13 September 2023
GlobeNewsWire
Wednesday, 21 June 2023
GlobeNewsWire
Thursday, 25 May 2023
Zacks Investment Research
Monday, 27 February 2023
Seeking Alpha
Tuesday, 14 February 2023
Zacks Investment Research
Monday, 13 February 2023
Zacks Investment Research
Monday, 6 February 2023
Zacks Investment Research
Wednesday, 1 February 2023
Zacks Investment Research
Thursday, 12 January 2023
Zacks Investment Research
Wednesday, 28 December 2022
Zacks Investment Research
Friday, 16 December 2022
GlobeNewsWire
Wednesday, 23 November 2022
Zacks Investment Research
Thursday, 3 November 2022
Zacks Investment Research
Thursday, 4 August 2022
Zacks Investment Research
  • What's the price of Mesa Laboratories stock today?

    One share of Mesa Laboratories stock can currently be purchased for approximately $70.21.

  • When is Mesa Laboratories's next earnings date?

    Unfortunately, Mesa Laboratories's (MLAB) next earnings date is currently unknown.

  • Does Mesa Laboratories pay dividends?

    Yes, Mesa Laboratories pays dividends and its trailing 12-month yield is 0.48% with -1% payout ratio.It means that the company is paying a dividend while loss making. The last Mesa Laboratories stock dividend of $0.16 was paid on 15 Dec 2021.

  • How much money does Mesa Laboratories make?

    Mesa Laboratories has a market capitalization of 716.56M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.32% to 216.19M US dollars.

  • What is Mesa Laboratories's stock symbol?

    Mesa Laboratories, Inc. is traded on the NASDAQ under the ticker symbol "MLAB".

  • What is Mesa Laboratories's primary industry?

    Company operates in the Technology sector and Hardware, Equipment & Parts industry.

  • How do i buy shares of Mesa Laboratories?

    Shares of Mesa Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Mesa Laboratories's key executives?

    Mesa Laboratories's management team includes the following people:

    • Mr. Gary M. Owens Chief Executive Officer, Pres & Director(age: 57, pay: $743,840)
    • Mr. John V. Sakys Chief Financial Officer & Chief Accounting Officer(age: 56, pay: $421,060)
    • Mr. Gregory T. DiNoia Senior Vice President of Commercial Operations(age: 60, pay: $361,140)
    • Mr. Brian David Archbold Senior Vice President of Continuous Improvement & Operations(age: 50, pay: $315,850)
  • How many employees does Mesa Laboratories have?

    As Jul 2024, Mesa Laboratories employs 698 workers.

  • When Mesa Laboratories went public?

    Mesa Laboratories, Inc. is publicly traded company for more then 41 years since IPO on 29 Feb 1984.

  • What is Mesa Laboratories's official website?

    The official website for Mesa Laboratories is mesalabs.com.

  • Where are Mesa Laboratories's headquarters?

    Mesa Laboratories is headquartered at 12100 West Sixth Avenue, Lakewood, CO.

  • How can i contact Mesa Laboratories?

    Mesa Laboratories's mailing address is 12100 West Sixth Avenue, Lakewood, CO and company can be reached via phone at +30 39878000.

Mesa Laboratories company profile:

Mesa Laboratories, Inc.

mesalabs.com
Exchange:

NASDAQ

Full time employees:

736

Industry:

Hardware, Equipment & Parts

Sector:

Technology

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

12100 West Sixth Avenue
Lakewood, CO 80228

CIK: 0000724004
ISIN: US59064R1095
CUSIP: 59064R109